Dr. Srinath Sundararajan, MD
1331 W Grand Pkwy N Ste 340, Katy, TX 77493 • +1-559-555-3997
Medical Education: Accredited U.S. Medical School (Class of 1998)
What This Doctor Actually Performs: CMS Medicare Utilization & Katy Percentiles
NPI #1316176597 • CBSA Regional • Hematology-Oncology
Operating out of Katy, TX (1331 W Grand Pkwy N Ste 340), Hematology-Oncology clinician Dr. Srinath Sundararajan, MD (accredited MD/DO training, 1998) maintains a mid-cohort balanced caseload (50th Katy percentile) (74.87th TX percentile; Z-score +0.60σ across 130,743 documented services) with sub-specialty concentration in 123 Active CMS HCPCS Codes.
Granular CPT/HCPCS billing distribution at 1331 W Grand Pkwy N Ste 340 shows Dr. Srinath Sundararajan's primary concentration in Moderate-to-High Complexity Internal Medicine Follow-Up (code 99214: 1724x/yr, 50th local percentile) alongside Established Preventive & Chronic Care Visit (99213: 996x/yr, $33–$48).
Cash-pay intake data for NPI 1316176597 (1331 W Grand Pkwy N Ste 340, Katy) indicates $209.00 typical out-of-pocket visit spend against a $209.00 locality benchmark, paired with 15-minute average reception wait and 4.87/5 biomarker openness.
Credentialed as an MD specialist with 28 years post-graduation experience since completing medical school at an LCME/COCA institution (1998), Dr. Sundararajan coordinates 123 Active CMS HCPCS Codes workups from 1331 W Grand Pkwy N Ste 340 (+1-559-555-3997).
Compared against Katy, TX Hematology-Oncology peers
130,743 annual services across 364 beneficiaries
Standard deviations from TX Hematology-Oncology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Moderate-to-High Complexity Internal Medicine Follow-Up | 1,724 | 50th | $43 – $60 |
| 99213 | Established Preventive & Chronic Care Visit | 996 | 51th | $33 – $48 |
| 93000 | In-Office 12-Lead Resting Electrocardiogram | 498 | 50th | $25 – $40 |
| G0439 | Annual Preventive Wellness & Cardiometabolic Risk Assessment | 383 | 52th | $51 – $70 |
| 99204 | Comprehensive New Patient Internal Medicine Diagnostic Visit | 230 | 51th | $60 – $83 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (123 HCPCS billing breadth) | 126,911 | 50th | $45 – $65 |
Are you Dr. Srinath Sundararajan? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Katy, TX:
<a href="https://dotmd.com/doctors/srinath-sundararajan-md-katy-tx-1316176597" title="Dr. Srinath Sundararajan, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1316176597.svg" alt="Dr. Srinath Sundararajan Hematology-Oncology Badge" width="280" height="72" /></a>
Dr. Srinath Sundararajan, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Sundararajan National Provider Identifier | NPI #1316176597 (MD) | CMS NPPES Registry (77493) |
| Dr. Sundararajan Katy CMS Volume Rank | 50.00th Pct (130,743 CMS svcs; Z +0.600σ) | CMS Medicare Part B (TX Hematology-Oncology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Katy, TX) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 15 min lobby wait | 9 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.76/5 Listening • 4.87/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Srinath Sundararajan
Other High-Volume Hematology-Oncology Specialists in Katy, TX
Ranked strictly by CMS Medicare volumeDr. Sundararajan Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Katy, TX.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Srinath Sundararajan community threads and patient logs by age, biological sex, dosage, and treatment duration.